Side effects of commonly prescribed cardiac medications such as anti-arrhythmics have specific implications for athletic performance in athletes with cardiovascular disease. Similarly, non-cardiac medications such as stimulants and anti-depressants may have more pronounced side effects in the setting of athletic activity due to the combination of endogenous and exogenous sympathetic stimulation and altered thermoregulation. This chapter is a summary of the available literature on (a) the implications of prescription medications, both cardiac and non-cardiac, on cardiovascular performance and cardiovascular health of athletic persons, and (b) the implications of potentially performance enhancing drugs known to be widely used by elite and recreational athletes on cardiovascular performance and cardiovascular health.
Cardiovascular side effects of commonly prescribed medications and performance enhancing drugs and special considerations for the athlete / Brosnan, Mj; Adami, P. - (2020), pp. 513-530. [10.1007/978-3-030-35374-2_27].
Cardiovascular side effects of commonly prescribed medications and performance enhancing drugs and special considerations for the athlete
Adami P
Ultimo
Writing – Original Draft Preparation
2020
Abstract
Side effects of commonly prescribed cardiac medications such as anti-arrhythmics have specific implications for athletic performance in athletes with cardiovascular disease. Similarly, non-cardiac medications such as stimulants and anti-depressants may have more pronounced side effects in the setting of athletic activity due to the combination of endogenous and exogenous sympathetic stimulation and altered thermoregulation. This chapter is a summary of the available literature on (a) the implications of prescription medications, both cardiac and non-cardiac, on cardiovascular performance and cardiovascular health of athletic persons, and (b) the implications of potentially performance enhancing drugs known to be widely used by elite and recreational athletes on cardiovascular performance and cardiovascular health.| File | Dimensione | Formato | |
|---|---|---|---|
|
Brosnan_Cardiovascular_2020 (1)_compressed.pdf
solo gestori archivio
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
12.65 MB
Formato
Adobe PDF
|
12.65 MB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.


